SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 86.79 |
| Enterprise Value ($M) | 59.66 |
| Book Value ($M) | 25.37 |
| Book Value / Share | 0.40 |
| Price / Book | 3.42 |
| NCAV ($M) | 17.81 |
| NCAV / Share | 0.28 |
| Price / NCAV | 4.87 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.28 |
| Return on Assets (ROA) | -0.73 |
| Return on Equity (ROE) | -1.20 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.22 |
| Current Ratio | 2.22 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 37.26 |
| Assets | 44.81 |
| Liabilities | 19.44 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Slate Path Capital LP | |||
| 13G/A | Bleichroeder LP | |||
| 13G | BlackRock, Inc. | 4.98 | -3.88 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 8,847 | 105,392 | 8.39 | |
| 30,313 | 57,637 | 52.59 | |
| 20,846 | 97,814 | 21.31 | |
| 21,376 | 97,870 | 21.84 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CSBR – Champions Oncology, Inc. | CSCI – COSCIENS Biopharma Inc. |
| CTXR – Citius Pharmaceuticals, Inc. | CVKD – Cadrenal Therapeutics, Inc. |
| CYCC – Cyclacel Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io